/LABD
LABD Stock - Direxion Daily S&P Biotech Bear 3X Shares
Financial Services|Asset Management - LeveragedAMEX
$18.51-7.26%
$1.45 (-7.26%) • Jan 14
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $20.36
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for LABD
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$18.32 – $18.70
TARGET (TP)$21.29
STOP LOSS$17.03
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-4.06
52W High$160.50
52W Low$17.43
Avg VolumeN/A
Income Statement (Fiscal Year)
Loading financial data...
Company Overview
The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
LABDLoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about LABD
What is LABD's current stock price?
Direxion Daily S&P Biotech Bear 3X Shares (LABD) is currently trading at $18.51 per share. The stock has moved -7.26% today.
What is the analyst price target for LABD?
No analyst price targets are currently available for this stock.
What sector is Direxion Daily S&P Biotech Bear 3X Shares in?
Direxion Daily S&P Biotech Bear 3X Shares operates in the Financial Services sector, specifically within the Asset Management - Leveraged industry. The company is traded on the AMEX exchange.
What is LABD's market cap?
Direxion Daily S&P Biotech Bear 3X Shares has a market capitalization of $0.04 billion, making it a small-cap company.
Does LABD pay dividends?
No, Direxion Daily S&P Biotech Bear 3X Shares does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorBITI
ProShares Short Bitcoin ETF
$20.70
Mkt Cap: $0.1B
DIG
ProShares Ultra Oil & Gas
$41.42
Mkt Cap: $0.1B
DRIP
Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X Shares
$8.24
Mkt Cap: $0.0B
DRN
Direxion Daily Real Estate Bull 3X Shares
$9.12
Mkt Cap: $0.1B
GLL
ProShares UltraShort Gold
$22.63
Mkt Cap: $0.1B
INDL
Direxion Daily MSCI India Bull 2X Shares
$55.09
Mkt Cap: $0.1B
JDST
Direxion Daily Junior Gold Miners Index Bear 2X Shares
$2.11
Mkt Cap: $0.0B
MAGX
Roundhill Daily 2X Long Magnificent Seven ETF
$55.03
Mkt Cap: $0.1B
SARK
Tradr 1X Short Innovation Daily ETF
$27.89
Mkt Cap: $0.1B
TSLS
Direxion Daily TSLA Bear 1X Shares
$5.19
Mkt Cap: $0.1B
Explore stocks similar to LABD for comparison